Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice.

Jong-Ho KimI-Rang LimHyung Joon JooChi-Yeon ParkSeung-Cheol ChoiHan Saem JeongSoon Jun Hong

Published in: Molecular medicine (Cambridge, Mass.) (2019)

This study suggests fimasartan could be an efficient strategy for reduction of atherosclerotic progression, with a decrease in immune response and systemic inflammation.

Keyphrases

immune response
oxidative stress
toll like receptor
dendritic cells
vascular smooth muscle cells